News Snapshot:
A new study led by Chinese university scientists has identified a compound derived from the antiviral drug remdesivir that exhibits potential as an oral treatment for COVID -19. Published in the journal Science Translational Medicine, the study shows that ATV006 , which was synthesized from the remdesivir derivative GS - 441524 , demonstrated improved oral absorption and robust antiviral efficacy against SARS- CoV -2 and variants in animal tests. According to previous studies, GS - 441524 , though effective against SARS- CoV -2, suffers from poor oral bioavailability, which hampers its further development as an oral drug . In the...
